Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™

Therese B. Bevers; Benjamin O. Anderson; Ermelinda Bonaccio; Sandra Buys; Mary B. Daly; Peter J. Dempsey; William B. Farrar; Irving Fleming; Judy E. Garber; Randall E. Harris; Alexandra S. Heerdt; Mark Helvie; John G. Huff; Nazanin Khakpour; Seema A. Khan; Helen Krontiras; Gary Lyman; Elizabeth Rafferty; Sara Shaw; Mary Lou Smith; Theodore N. Tsangaris; Cheryl Williams; Thomas Yaneeklov

doi:10.6004/jnccn.2009.0070

Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™

Therese B. Bevers, Benjamin O. Anderson, Ermelinda Bonaccio, Sandra Buys, Mary B. Daly, Peter J. Dempsey, William B. Farrar, Irving Fleming, Judy E. Garber, Randall E. Harris, Alexandra S. Heerdt, Mark Helvie, John G. Huff, Nazanin Khakpour, Seema A. Khan, Helen Krontiras, Gary Lyman, Elizabeth Rafferty, Sara Shaw, Mary Lou SmithTheodore N. Tsangaris, Cheryl Williams, Thomas Yaneeklov

Clinical Cancer Prevention

Research output: Contribution to journal › Review article › peer-review

281 Scopus citations

Abstract

The goal of these guidelines is to give health care providers a practical and consistent framework for screening and evaluating a spectrum of breast lesions. Clinical judgment should always be an important component of optimal patient management. If the physical breast examination, radiologic imaging, and pathologic findings are not concordant, the clinician should carefully reconsider the assessment of the patient's problem. Involving patients in treatment decisions empowers them to determine an acceptable level of breast cancer risk in the screening and/or follow-up procedures.

Original language	English (US)
Pages (from-to)	1060-1096
Number of pages	37
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	7
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2009.0070
State	Published - 2009

Keywords

Biopsy
Breast carcinoma
Carcinoma in situ
Diagnosis
Hyperplasia
Mammography
NCCN Clinical Practice Guidelines
Risk assessment
Screening

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2009.0070

Cite this

Bevers, T. B., Anderson, B. O., Bonaccio, E., Buys, S., Daly, M. B., Dempsey, P. J., Farrar, W. B., Fleming, I., Garber, J. E., Harris, R. E., Heerdt, A. S., Helvie, M., Huff, J. G., Khakpour, N., Khan, S. A., Krontiras, H., Lyman, G., Rafferty, E., Shaw, S., ... Yaneeklov, T. (2009). Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 7(10), 1060-1096. https://doi.org/10.6004/jnccn.2009.0070

Bevers, TB, Anderson, BO, Bonaccio, E, Buys, S, Daly, MB, Dempsey, PJ, Farrar, WB, Fleming, I, Garber, JE, Harris, RE, Heerdt, AS, Helvie, M, Huff, JG, Khakpour, N, Khan, SA, Krontiras, H, Lyman, G, Rafferty, E, Shaw, S, Smith, ML, Tsangaris, TN, Williams, C & Yaneeklov, T 2009, 'Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 10, pp. 1060-1096. https://doi.org/10.6004/jnccn.2009.0070

@article{44c75e55000b4fda88731eb0404b7a4d,

title = "Breast cancer screening and diagnosis: Clinical practice guidelines in oncology{\texttrademark}",

abstract = "The goal of these guidelines is to give health care providers a practical and consistent framework for screening and evaluating a spectrum of breast lesions. Clinical judgment should always be an important component of optimal patient management. If the physical breast examination, radiologic imaging, and pathologic findings are not concordant, the clinician should carefully reconsider the assessment of the patient's problem. Involving patients in treatment decisions empowers them to determine an acceptable level of breast cancer risk in the screening and/or follow-up procedures.",

keywords = "Biopsy, Breast carcinoma, Carcinoma in situ, Diagnosis, Hyperplasia, Mammography, NCCN Clinical Practice Guidelines, Risk assessment, Screening",

author = "Bevers, {Therese B.} and Anderson, {Benjamin O.} and Ermelinda Bonaccio and Sandra Buys and Daly, {Mary B.} and Dempsey, {Peter J.} and Farrar, {William B.} and Irving Fleming and Garber, {Judy E.} and Harris, {Randall E.} and Heerdt, {Alexandra S.} and Mark Helvie and Huff, {John G.} and Nazanin Khakpour and Khan, {Seema A.} and Helen Krontiras and Gary Lyman and Elizabeth Rafferty and Sara Shaw and Smith, {Mary Lou} and Tsangaris, {Theodore N.} and Cheryl Williams and Thomas Yaneeklov",

year = "2009",

doi = "10.6004/jnccn.2009.0070",

language = "English (US)",

volume = "7",

pages = "1060--1096",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "10",

}

TY - JOUR

T1 - Breast cancer screening and diagnosis

T2 - Clinical practice guidelines in oncology™

AU - Bevers, Therese B.

AU - Anderson, Benjamin O.

AU - Bonaccio, Ermelinda

AU - Buys, Sandra

AU - Daly, Mary B.

AU - Dempsey, Peter J.

AU - Farrar, William B.

AU - Fleming, Irving

AU - Garber, Judy E.

AU - Harris, Randall E.

AU - Heerdt, Alexandra S.

AU - Helvie, Mark

AU - Huff, John G.

AU - Khakpour, Nazanin

AU - Khan, Seema A.

AU - Krontiras, Helen

AU - Lyman, Gary

AU - Rafferty, Elizabeth

AU - Shaw, Sara

AU - Smith, Mary Lou

AU - Tsangaris, Theodore N.

AU - Williams, Cheryl

AU - Yaneeklov, Thomas

PY - 2009

Y1 - 2009

N2 - The goal of these guidelines is to give health care providers a practical and consistent framework for screening and evaluating a spectrum of breast lesions. Clinical judgment should always be an important component of optimal patient management. If the physical breast examination, radiologic imaging, and pathologic findings are not concordant, the clinician should carefully reconsider the assessment of the patient's problem. Involving patients in treatment decisions empowers them to determine an acceptable level of breast cancer risk in the screening and/or follow-up procedures.

AB - The goal of these guidelines is to give health care providers a practical and consistent framework for screening and evaluating a spectrum of breast lesions. Clinical judgment should always be an important component of optimal patient management. If the physical breast examination, radiologic imaging, and pathologic findings are not concordant, the clinician should carefully reconsider the assessment of the patient's problem. Involving patients in treatment decisions empowers them to determine an acceptable level of breast cancer risk in the screening and/or follow-up procedures.

KW - Biopsy

KW - Breast carcinoma

KW - Carcinoma in situ

KW - Diagnosis

KW - Hyperplasia

KW - Mammography

KW - NCCN Clinical Practice Guidelines

KW - Risk assessment

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=74049099557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049099557&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2009.0070

DO - 10.6004/jnccn.2009.0070

M3 - Review article

C2 - 19930975

AN - SCOPUS:74049099557

SN - 1540-1405

VL - 7

SP - 1060

EP - 1096

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this